Dechra turnover up by 12%
Date added:
14/01/2015
ANIMAL pharmaceuticals firm Dechra has increased revenue by about 12%, in line with management expectations for both revenue and operating profit. The Cheshire-headquartered company said it was pleased with the half-year financial results for the period ended December 31 in an unaudited update ahead of the announcement of results on February 23. The increased revenue was against a soft comparator period in the previous year. "Good momentum” has continued in Europe with sales growing 7% and there was 59% sales growth in the...
Back to all news